We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+0.47%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$80.2B
AUM Growth
-$2.64B
(-3.2%)
Cap. Flow
-$1.24B
Cap. Flow
% of AUM
-1.54%
Top 10 Holdings %
Top 10 Hldgs %
15.46%
Holding
1,891
New
54
Increased
680
Reduced
1,031
Closed
114
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$639M |
| 2 |
JPMorgan Chase
JPM
|
+$525M |
| 3 |
JD.com
JD
|
+$297M |
| 4 |
Itaú Unibanco
ITUB
|
+$222M |
| 5 |
ATVI
Activision Blizzard
ATVI
|
+$217M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$955M |
| 2 |
Citigroup
C
|
+$523M |
| 3 |
Nektar Therapeutics
NKTR
|
+$334M |
| 4 |
SLB Ltd
SLB
|
+$292M |
| 5 |
Alibaba
BABA
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.67% |
| 2 | Consumer Discretionary | 14.85% |
| 3 | Healthcare | 13.25% |
| 4 | Technology | 13.05% |
| 5 | Energy | 11.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Regeneron Pharmaceuticals
REGN
$72.9B
| $13.4M | 0.02% |
39,022
-6,596
| -14% | -$2.29M |
|
652
Agios Pharmaceuticals
AGIO
$2.14B
| $13.3M | 0.02% |
162,583
+20,300
| +14% | +$1.57M |
|
653
Herc Holdings
HRI
$4.95B
| $13.3M | 0.02% |
+204,169
| New | +$13.3M |
|
654
Hess Midstream
HESM
$5.13B
| $13.2M | 0.02% |
693,740
-1,270
| -0.2% | -$26.2K |
|
655
IQVIA
IQV
$40.5B
| $13.1M | 0.02% |
134,023
-16,543
| -11% | -$1.67M |
|
656
Radian Group
RDN
$5.22B
| $13.1M | 0.02% |
690,576
-1,556,725
| -69% | -$32.8M |
|
657
Aon
AON
$81.4B
| $13.1M | 0.02% |
93,623
-155,531
| -62% | -$21.8M |
|
658
GameStop
GME
$9.94B
| $13.1M | 0.02% |
4,148,312
+830,404
| +25% | +$3.39M |
|
659
Delek Logistics
DKL
$3.07B
| $13.1M | 0.02% |
460,343
+500
| +0.1% | +$15.3K |
|
660
ITT
ITT
$17.8B
| $13M | 0.02% |
265,592
-36,605
| -12% | -$1.93M |
|
661
Manitowoc
MTW
$527M
| $13M | 0.02% |
456,813
+22,484
| +5% | +$771K |
|
|
ORBK
662
DELISTED
Orbotech Ltd
ORBK
| $12.9M | 0.02% |
207,045
-19,527
| -9% | -$1.07M |
|
663
Customers Bancorp
CUBI
$2.69B
| $12.8M | 0.02% |
439,954
+783
| +0.2% | +$23.5K |
|
|
WMGI
664
DELISTED
Wright Medical Group Inc
WMGI
| $12.8M | 0.02% |
645,664
+2,936
| +0.5% | +$63K |
|
|
BNCL
665
DELISTED
Beneficial Bancorp, Inc.
BNCL
| $12.7M | 0.02% |
818,410
+4,323
| +0.5% | +$68.9K |
|
|
XEC
666
DELISTED
CIMAREX ENERGY CO
XEC
| $12.7M | 0.02% |
135,370
-73,187
| -35% | -$7.8M |
|
667
Supernus Pharmaceuticals
SUPN
$2.77B
| $12.5M | 0.02% |
272,310
-139,702
| -34% | -$5.83M |
|
668
Wells Fargo
WFC
$263B
| $12.2M | 0.02% |
233,040
-3,043,478
| -93% | -$181M |
|
|
PPL
669
PPL Corp
PPL
$27.3B
| $12.1M | 0.02% |
426,051
+76,163
| +22% | +$2.27M |
|
670
Cencora
COR
$62.2B
| $12M | 0.02% |
139,231
-109,610
| -44% | -$10.5M |
|
671
Hyatt Hotels
H
$17.8B
| $11.9M | 0.01% |
+156,035
| New | +$12.3M |
|
672
Enpro
NPO
$6.63B
| $11.8M | 0.01% |
152,358
+142,841
| +1,501% | +$11.8M |
|
673
PDF Solutions
PDFS
$1.87B
| $11.7M | 0.01% |
1,004,990
+546
| +0.1% | +$7.26K |
|
|
WAIR
674
DELISTED
WESCO Aircraft Holdings Inc.
WAIR
| $11.6M | 0.01% |
1,130,701
-539,038
| -32% | -$4.56M |
|
675
Costco
COST
$429B
| $11.6M | 0.01% |
61,477
-40,749
| -40% | -$7.69M |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q1 2018 Portfolio in Review
As of Q1 2018, OppenheimerFunds held 1,891 positions worth $80.2B, down 3.2% from $82.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
OppenheimerFunds's Q1 2018 filing shows 54 new, 680 increased, 1,031 reduced and 114 closed positions. Its largest new stake was Avaya Holdings Corp. Common Stock: 5,049,928 shares worth $113M. The largest sale was Alphabet (Google) Class C, an estimated $955M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- OppenheimerFunds's largest Q1 2018 buy was Avaya Holdings Corp. Common Stock: 5,049,928 shares worth $113M.
- OppenheimerFunds added most to Alphabet (Google) Class A in Q1 2018, an estimated $639M increase.
- OppenheimerFunds's biggest Q1 2018 reduction was Alphabet (Google) Class C, cutting an estimated $955M.
- OppenheimerFunds fully exited Bioverativ Inc. Common Stock in Q1 2018, selling an estimated $77.3M.
- OppenheimerFunds's ten largest holdings make up 15% of its $80.2B portfolio in Q1 2018.
- OppenheimerFunds opened 54 new positions and closed 114 in Q1 2018.
- OppenheimerFunds's portfolio value fell 3.2% quarter-over-quarter to $80.2B.
Based on OppenheimerFunds's 13F filing for Q1 2018, filed 11 May 2018.